Cancer Cells and Marijuana, Update US National Cancer Institute

Is-Marijuana-Prohibition-a-Suppression-of-The-Divine-Feminine-CannabisThe following article is not endorsed by Wellness in Health or any subsidiary but we do believe in truthful information and being educated.  Recently the National Cancer Institute of the NIH (National Institutes of Health) updated there website to include information regarding the medical benefits of Marijuana. We have incorporated a direct link to the National Cancer Institute site above that is underlined.  When we consider the purpose of legalizing a substance, that should be controlled, we should remember that when legalized it is controlled and hopefully the process would prevent dangerous adulteration and limit the access of that substance to those that would benefit medically. Legalization is a means to control and tax what is presently an out of control substance.  It has been argued that marijuana is a gateway drug.  Though there are correlations between marijuana use and other drugs, there is no conclusive evidence that one actually causes the other. A 1999 report from the Institute of Medicine, which is part of the National Academy of Sciences states: “In the sense that marijuana use typically precedes rather than follows initiation into the use of other illicit drugs, it is indeed a gateway drug. However, it does not appear to be a gateway drug to the extent that it is the cause or even that it is the most significant predictor of serious drug abuse; that is, care must be taken not to attribute cause to association.”  This is further discussed here: http://www.factcheck.org/2015/ Is marijuana a gateway drug .

cancer

Marijuana Kills Cancer Cells, Admits US National Cancer Institute

States in the US may be one step closer to legalizing the recreational use of marijuana, especially now that the National Cancer Institute (NCI) has updated its website FAQs to include studies proving cannabis as a natural remedy for cancer.

As InfoWars reports, NCI updated its page to include various studies revealing how cannabis “may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow” while also protecting normal, healthy cells.

NCI stated:

“A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.”

 

The full list provided by the National Cancer Institute follows:

  • Cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.
  • Cannabinoids may protect against inflammation of the colon and may have potential in reducing the risk of colon cancer, and possibly in its treatment.
  • A laboratory study of delta -9-THC in hepatocellular carcinoma (liver cancer) cells showed itdamaged or killed the cancer cells. The same study of delta-9-THC in models of liver cancer showed that it had anti-tumor effects. Delta-9-THC has been shown to cause these effects by acting on molecules that may also be found in non-small cell lung cancer cells and breast cancer cells.
  • A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
  • A laboratory study of cannabidiol in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.These studies are considered by the NCI as preclinical. They were all done using animals. According to them, no clinical trials of cannabis use for the treatment of cancer in humans have been published.
  • Delta-9-THC and other cannabinoids stimulate appetite and can increase food intake.
  • Cannabinoid receptors have been studied in the brain, spinal cord, and nerve endings throughout the body to understand their roles in pain relief.
  • Cannabinoids have been studied for anti-inflammatory effects that may play a role in pain relief.

Data from 2010 (Credit: Portland.Indymedia.org)

That’s not all, in April, the NIDA stated:

“Evidence from one animal study suggests that extracts from whole-plant marijuana can shrink one of the most serious types of brain tumors. Research in mice showed that theseextracts, when used with radiation, increased the cancer-killing effects of the radiation.”

How can government agencies conclude the above and the FDA still classify marijuana as a “drug with no medicinal purposes”? Perhaps this video will enlighten you on the reasons why.

Despite the numerous, proven benefits of marijuana, the federal government aims to keep it illegal while the FDA approves expensive prescription drugs with more side effects and far less research. 

What are your thoughts on this news? Share this article and comment your thoughts below.

This article (Marijuana Kills Cancer Cells, Admits US National Cancer Institute) is free and open source. You have permission to republish this article under a Creative Commons license with attribution to the author and TrueActivist.com

Prostate Biopsy, MRI, PSA, and Prostate Cancer

biopsyWnH

In the 1980s a technique was developed in which tissues samples were taken systematically from the prostate in hopes of locating a tumor within the prostate gland. Typically men whose physicians discover elevations in PSA levels, a common blood test to screen for prostate cancer, trigger over 1 million prostate biopsies annually. Most biopsies performed are conventional biopsies otherwise known as blind biopsies. Men who undergo these biopsies dread them and for good reason. They are painful and 75 percent of the biopsies performed are negative for prostate cancer.  

Despite this many men with negative biopsies but elevated PSA levels may still harbor malignant tumors – tumors missed by these conventional biopsies. Most men who have a prostate biopsy will have additional biopsies. This is especially true as many men with negative biopsies but elevated PSA levels may still harbor malignant tumors – tumors missed by conventional blind biopsies.  

A study at Johns Hopkins in 2011 found a significant rise in serious complications post prostate biopsy requiring hospitalization. They found that this common outpatient procedure, used to diagnose prostate cancer, was associated with a 6.9 percent rate of hospitalization within 30 days of biopsy. This does not include complications that were treated in an emergency department or outpatient setting. In 33% of men undergoing prostate biopsy, side effects that men consider a “moderate or major problem” will be experienced, including pain, fever, bleeding, infection, and transient urinary difficulties. A rise in PSA (prostate-specific antigen) may not warrant immediate biopsy, especially because 20%-30% of men will drop back to a lower level simply by repeating the test.  

A PSA (prostate-specific antigen) test is still beneficial for you and your health care provider. Despite the fact that a majority of men with an elevated PSA do not in fact have prostate cancer, but may have other reasons for an elevated PSA such as prostatitis or benign prostatic hyperplasia (BPH).  

In August 30, 2011 an article entitled “Prostate Cancer: The Dreaded Prostate Biopsy and Alternatives” points out the alternatives to a traditional biopsy. It is now 2015. It is important to note that imaging of a tumor as discussed then never under staged a tumor but it actually makes it look worse than it is. Also in 2011 doctors at UCLA published a study on “Prostate cancer now detectable using imaging-guided biopsy”. This actually makes sense. If you are going to have a biopsy of your prostate there truly is no point in having a conventional blind biopsy of the prostate. The MRI options available today to detect prostate cancer with imaging make a conventional biopsy look Jurassic in comparison. If you suspect you have prostate cancer you should be asking your specialist health care provider about having an MRI before you consider a biopsy.

This article was originally published October 16, 2015 and has been adapted by the publishing author with appropriate links. The author is affiliated with Best Prostate ® a dietary supplement for prostate health.  If you have an enlarged prostate or are living with the symptoms of an enlarged prostate you may want to visit www.bestprostate.com to learn about effective natural alternatives as compared to prescription medications.